Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Fentanyl and Buccal Midazolam for Symptom Control in Dying Patients
NCT02009306Phase 4Completed
- Sponsor
- Gloucestershire Hospitals NHS Foundation Trust
- Start
- Jan 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fentanyl (transdermal patch + oral transmucosal lozenge), midazolam in cancer, sponsored by Gloucestershire Hospitals NHS Foundation Trust. Started Jan 2017; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)midazolam
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02009306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02009306.